United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69367-409_94a7ec84-91fc-4cb2-9ddc-49e82e94408f
- Product NDC
- 69367-409
- Form
- TABLET
- Composition / generic term
- Dapsone
- Labeler
- Westminster Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250821
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (69367-409-01) · 69367-409-01
- 30 TABLET in 1 BOTTLE (69367-409-30) · 69367-409-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →